Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Tocilizumab vs Compound Betamethasone in Knee Rheumatoid Arthritis
NCT03215407Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Aug 2017
- Primary completion
- Dec 2017
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03215407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03215407.